HomeVYGR • NASDAQ
add
Voyager Therapeutics Inc
Previous close
$3.28
Day range
$3.20 - $3.36
Year range
$2.75 - $9.55
Market cap
182.61M USD
Avg Volume
358.83K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 6.47M | -66.83% |
Operating expense | 9.64M | 12.00% |
Net income | -31.02M | -173.80% |
Net profit margin | -479.24 | -725.56% |
Earnings per share | -0.53 | -165.00% |
EBITDA | -33.68M | -124.72% |
Effective tax rate | -0.12% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 236.02M | -40.93% |
Total assets | 353.24M | -24.78% |
Total liabilities | 80.54M | -37.42% |
Total equity | 272.70M | — |
Shares outstanding | 55.34M | — |
Price to book | 0.66 | — |
Return on assets | -23.24% | — |
Return on capital | -26.35% | — |
Cash Flow
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -31.02M | -173.80% |
Cash from operations | -37.90M | -164.48% |
Cash from investing | 41.20M | 142.89% |
Cash from financing | 82.00K | -99.93% |
Net change in cash | 3.39M | -95.52% |
Free cash flow | -26.50M | -134.38% |
About
Founded
2013
Headquarters
Website
Employees
172